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Pancreas development is regulated by a variety of molecular signals [50-52]. One 
redox-sensitive transcription factor essential for pancreas development is pancreatic and 
duodenal homeobox 1 (Pdx1), which signals differentiation of pancreatic precursor cells, 
distinguishing them from endoderm cells in the developing gut. Pdx1 becomes 
progressively restricted to beta cells where it regulates the promoter activity of 
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preproinsulin [53]. Pdx1 is essential to the maintenance of beta cell function and 
survival, with ablation of Pdx1 signaling leading to pancreatic agenesis [54]. 
The activity of Pdx1 is sensitive to redox signaling. During hyperglycemia, as 
blood glucose and ROS climb, the DNA binding activity of Pdx1 decreases; this activity 
is restored with antioxidant treatments such as NAC [55, 56]. Kaneto et al [55] further 
showed that increased ROS in rat islets caused activation of the c-Jun N-terminal kinase 
(JNK) pathway, leading to a marked reduction of insulin production, and blocking the 
JNK pathway had a cytoprotective effect on beta cells experiencing oxidative stress.  
Developmental exposure to ROS has also been shown to affect beta cell growth in 
vivo. We recently demonstrated a reduction in beta cell mass and a shortened pancreas 
phenotype in the zebrafish embryo after developmental exposure to the pro-oxidant tert 
butyl hydroperoxide [57]. H2O2, has been shown to specifically activate the ERK-1/ERK-
2 pathway in the developing pancreas and initiate beta cell differentiation [58]. 
Additional support for the importance of H2O2 redox signaling can be found in a study by 
Rovira et al, [59], in which treatment of zebrafish embryos with the pharmaceuticals 
disulfiram and methiopropamine resulted in disrupted proliferation and premature 
differentiation of pancreatic beta cells, and thus smaller islets. These pharmaceuticals 
inhibited the conversion of retinaldehyde to retinoic acid; retinoic acid can ablate H2O2 
mediated cell signaling in embryonic stem cells. Another study found that 
undernourished rat fetuses had small islets with high levels of activated ERK-1/ERK-2, 
further implicating ROS in beta cell development [60]. While a shift towards oxidative 
conditions in the beta cell can interfere with development and function of these cells, a 
reduction or loss of redox signaling due to inappropriate reductive redox conditions is 
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similarly detrimental. For example, exposure to high concentrations of NAC during 
pancreatic development in rats reduced the number of pancreatic progenitor cells; this 
finding persisted into adulthood, as rats exposed to NAC in utero had a 2.5- fold decrease 
in the number of beta cells [58].  
1.2.2	Redox	Signaling	Modulates	Beta	Cell	Function		
Modulation of antioxidant and cytoprotective gene expression has also been 
shown to affect the function of beta cells. Mitochondrial ROS triggers glucose-stimulated 
insulin secretion [61]; conversely, an increase in cellular antioxidant defenses is 
associated with impaired insulin secretion [61, 62]. However, understanding the role of 
redox signaling in beta cell function is quite complicated, with numerous contradictory 
findings. Some studies report that low levels of oxidative stress are required to stimulate 
insulin production [63-66]. Nrf2 null mice have lower serum insulin and elevated blood 
glucose [67], while Keap1 knockdown mice that constitutively activate Nrf2 on the 
Leptin-deficient background (ob/ob) have increased antioxidants but exacerbated 
systemic insulin resistance [68]. Others have demonstrated loss of Nrf2 in beta cells 
aggravates diabetes, while repeated Nrf2 activation attenuates diabetes [69, 70]. In a 
hypomorphic Keap1 knockdown model, constitutive activation of Nrf2 had a 
cytoprotective effect on pancreatic beta cells, making them more resistant to oxidative 
stress [70]. In addition, when Keap1 hypomorphs were crossed with a diabetic mouse 
model strain (db/db), islets with activated Nrf2 were highly responsive to glucose and the 
diabetic phenotype in the db/db mice was rescued [70]. The Keap1-knockdown mice also 
were protected against induction of diabetes and obesity by a high-calorie diet [70]. There 
are many factors that may explain these contradictory studies including differences in 
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timing, genetic background, endogenous antioxidant defenses, duration and repetition of 
the oxidative challenge, among others. Additional studies are required to fully understand 
the role of ROS in beta cell function, and whether there are any inherent differences 








































































































































































































































































































































































































































































































In this study, we present MCB staining of live zebrafish embryos as a technique to 
monitor glutathione redox dynamics during vertebrate embryonic development. We 
validated the responsiveness of MCB using well-characterized GSH modulators, and 
found it to be suitably sensitive to detect changes in GSH localization in vivo. During 
development, GSH utilization hotspots correlated closely with regions of high 
differentiation; these hotspots were differentially affected by GSH modulation. Some 
organs like the heart and brain displayed a greater resiliency against GSH depletion, 
while the gut was especially vulnerable to GSH modulation. When applied to test the 
effects of PFOS exposure on embryonic GSH homeostasis, MCB was able to discern 
bidirectional changes in GSH utilization effected by different doses of PFOS at distinct 
developmental timepoints, corroborating experimentally determined GSH concentrations 




























































































































































































































































































































































































































































































Pancreatic islet growth is perturbed by redox-active chemicals, but mechanisms 
governing this are unknown. We used zebrafish (Danio rerio) embryos to investigate 
roles of glutathione (GSH; predominant cellular redox buffer) and the transcription factor 
Nrf2a (Nfe2l2a; zebrafish Nrf2 co-ortholog) in islet morphogenesis. We delineated 
critical windows of redox susceptibility to β-cell morphogenesis, and, visualized Nrf2a 
expression in the pancreas using whole-mount immunohistochemistry at 96 hours post 
fertilization (hpf). Chemical GSH modulation at 48 hpf induced significant islet 
morphology changes persistent through 96 hpf. Decreased β-cell cluster area at 96 hpf 
resulted from exposures to prooxidants tert-Butylhydroperoxide (77.6 μM; 10-minutes at 
48 hpf) and tert-Butylhydroquinone (1 μM; 48-56 hpf). Conversely, exposures at this 
stage to antioxidants N-AcetylCysteine (100 μM; 48-72 hpf) and sulforaphane (20 μM; 
48-72 hpf) significantly increased islet areas. Nrf2a was also stabilized in the islet at this 
stage: 10-minute exposures to 77.6 μM tert-Butylhydroperoxide significantly increased 
Nrf2a protein in the islet, compared to control islets that lack Nrf2a; 10-minute exposures 
to higher (776 μM) tert-Butylhydroperoxide concentration induced Nrf2a in the entire 
pancreas. We assessed functional implications of Nrf2a changes using biotinylated-GSH 
to visualize in situ protein glutathionylation. Islets had high protein glutathionylation, 
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indicating oxidized GSH pools, congruent with low Nrf2a levels. The 10-minute high 
(776 μM) tert-Butylhydroperoxide exposure (induced Nrf2a globally) decreased global 
protein glutathionylation. Mutant fish expressing inactive Nrf2a were protected against 
abnormal islet morphology. Our data indicate disrupted redox homeostasis during 
pancreatic β-cell development impacts morphogenesis, with implications for disease 
states later in life. 
	
3.2	Significance	Statement	
Despite redox dysfunction being well-characterized as an underlying cause of 
pancreatic β-cell dysfunction and diabetes, there is little known about redox signaling 
during β-cell morphogenesis. Here, we demonstrate the decreased antioxidant defenses of 
the developing β-cell, and the specific sensitivity of this cell type to endogenous and 
exogenous redox stressors. Our work identifies a potential molecular target (Nrf2a) that 
induces abnormal β-cell morphology in response to redox disruptions. Moreover, our 
findings implicate that developmental exposure to exogenous stressors at distinct 
windows of susceptibility could diminish the reserve capacity of β-cells, rendering them 

















































































































































































































































μM	 tBOOH	 exposure	 at	 48	 hpf,	 we	 investigated	 Nrf2a	 dynamics	 and	 protein	
glutathionylation	 in	 response	 to	 tBOOH	 treatment.	 A	 10-minute	 77.6	 μM	 tBOOH	
exposure	 at	 48	 hpf	 resulted	 in	 100%	 fish	 expressing	 Nrf2a	 in	 pancreatic	 β-cells,	
sustained	 through	 96	 hpf	 (p<0.05;	 Fig.	 3).	 This	 was	 accompanied	 by	 a	 sustained	











against	Nrf2a	 stabilization	 in	pancreatic	 β-cells	 (Fig.	 3).	 In	Nrf2a	m/m	 fish,	which	
carry	 a	 mutation	 in	 the	 DNA-binding	 domain	 of	 Nrf2a,	 77.6	 μM	 tBOOH	 did	 not	
stabilize	Nrf2a	(Fig.	4).	An	opposite	result	was	seen	at	 the	10-fold	higher,	776	μM	
tBOOH	 treatment.	 This	 treatment	 stabilized	Nrf2a	 in	 the	mutant	 fish	 (Fig.	 3),	 in	 a	
pattern	similar	to	the	Nrf2a	wildtype	fish	(Fig.	3).	Concordant	with	transcriptional	




Upon	exposure	 to	 the	Nrf2a	activators	 tBHQ	and	SFN,	a	100%	of	 the	Nrf2a	















the	most	 dramatic	 response	with	 regards	 to	 both	morphology	 changes	 and	Nrf2a	
activation.	We	found	that	wildtype	embryos	were	more	susceptible	to	decreases	in	
both	 β-cell	 area,	 and	 the	 incidence	 of	 hypomorphic	 islets	 (Fig.	 6).	 Nrf2a	 wt/wt	
embryos	 showed	a	13%	reduction	 in	β-cell	 area	 (p<0.05)	and	a	300%	 increase	 in	
hypomorphic	islets.	Nrf2a	m/m	fish	on	the	other	hand,	showed	no	effects	with	either	
of	 these	 parameters	 (Fig.	 6).	 This	 demonstrates	 that	Nrf2a	 is	 essential	 for	 tBOOH	
mediated	 changes	 in	 β-cell	 morphology.	 We	 also	 measured	 fish	 length	 for	 both	


















































































































































































































































































































































































































































































































































































Upon chronic developmental exposures to 3.2 μM PFOS, 100% of the Nrf2a 
wt/wt embryos displayed aberrant cells expressing Nrf2a the endocrine pancreas 
(p<0.05; Fig. 1). However, these cells were not pancreatic β-cells. To investigate if these 
were α-cells, we repeated the experiment in Tg(gcga::eGFP) embryos, where the α-cells 
express GFP. We found that the Nrf2a positive cells were not α-cells either (p<0.05; Fig. 
1). At this developmental stage, the islet has approximately 90-100 cells, and less than 
1% of these are ε-cells; we see approximately 5-10 Nrf2a positive cells, indicating they 
are likely δ-cells [162, 202]. Co-exposure to a 100 μM NAC protected against changes 
in Nrf2a protein expression in the endocrine islet, indicating the sufficiency of GSH 
disruption to induce Nrf2a. Nrf2a m/m fish showed no changes in expression of Nrf2a 
compared to DMSO controls, implying Nrf2a upregulation is self-regulated at this dose 

















































































































































































































































































































































































































































































































































































[1] G.C. Dismukes, V.V. Klimov, S.V. Baranov, Y.N. Kozlov, J. DasGupta, A. 
Tyryshkin, The origin of atmospheric oxygen on Earth: the innovation of 
oxygenic photosynthesis, Proc Natl Acad Sci U S A 98(5) (2001) 2170-5. 
[2] K.J. Davies, The Oxygen Paradox, oxidative stress, and ageing, Archives of 
biochemistry and biophysics 595 (2016) 28-32. 
[3] S.C. Lu, Glutathione synthesis, Biochim Biophys Acta 1830(5) (2013) 3143-53. 
[4] S.C. Lu, Regulation of glutathione synthesis, Mol Aspects Med 30(1-2) (2009) 42-59. 
[5] F.Q. Schafer, G.R. Buettner, Redox environment of the cell as viewed through the 
redox state of the glutathione disulfide/glutathione couple, Free Radic Biol Med 
30(11) (2001) 1191-212. 
[6] E. Pineda-Molina, P. Klatt, J. Vazquez, A. Marina, M. Garcia de Lacoba, D. Perez-
Sala, S. Lamas, Glutathionylation of the p50 subunit of NF-kappaB: a mechanism 
for redox-induced inhibition of DNA binding, Biochemistry 40(47) (2001) 14134-
42. 
[7] N.L. Reynaert, A. van der Vliet, A.S. Guala, T. McGovern, M. Hristova, C. Pantano, 
N.H. Heintz, J. Heim, Y.S. Ho, D.E. Matthews, E.F. Wouters, Y.M. Janssen-
Heininger, Dynamic redox control of NF-kappaB through glutaredoxin-regulated 
S-glutathionylation of inhibitory kappaB kinase beta, Proc Natl Acad Sci U S A 
103(35) (2006) 13086-91. 
[8] M.A. Yusuf, T. Chuang, G.J. Bhat, K.S. Srivenugopal, Cys-141 glutathionylation of 
human p53: Studies using specific polyclonal antibodies in cancer samples and 
cell lines, Free Radic Biol Med 49(5) (2010) 908-17. 
[9] C.S. Velu, S.K. Niture, C.E. Doneanu, N. Pattabiraman, K.S. Srivenugopal, Human 
p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-
binding domain during oxidative stress, Biochemistry 46(26) (2007) 7765-80. 
[10] A.A. Mills, p53: link to the past, bridge to the future, Genes Dev 19(18) (2005) 
2091-9. 
[11] A.R. Timme-Laragy, M.E. Hahn, J.M. Hansen, A. Rastogi, M.A. Roy, Redox stress 
and signaling during vertebrate embryonic development: Regulation and 
responses, Semin Cell Dev Biol 80 (2018) 17-28. 
[12] L. Covarrubias, D. Hernandez-Garcia, D. Schnabel, E. Salas-Vidal, S. Castro-
Obregon, Function of reactive oxygen species during animal development: 
passive or active?, Dev Biol 320(1) (2008) 1-11. 
	
	 129 
[13] J.M. Hansen, C. Harris, Glutathione during embryonic development, Biochim 
Biophys Acta 1850(8) (2015) 1527-42. 
[14] L. Liu, D.L. Keefe, Cytoplasm mediates both development and oxidation-induced 
apoptotic cell death in mouse zygotes, Biol Reprod 62(6) (2000) 1828-34. 
[15] E. Salas-Vidal, H. Lomeli, S. Castro-Obregon, R. Cuervo, D. Escalante-Alcalde, L. 
Covarrubias, Reactive oxygen species participate in the control of mouse 
embryonic cell death, Exp Cell Res 238(1) (1998) 136-47. 
[16] J.A. Coffman, A. Coluccio, A. Planchart, A.J. Robertson, Oral-aboral axis 
specification in the sea urchin embryo III. Role of mitochondrial redox signaling 
via H2O2, Dev Biol 330(1) (2009) 123-30. 
[17] P.D. Ray, B.W. Huang, Y. Tsuji, Reactive oxygen species (ROS) homeostasis and 
redox regulation in cellular signaling, Cell Signal 24(5) (2012) 981-90. 
[18] G.M. Cohen, M. d'Arcy Doherty, Free radical mediated cell toxicity by redox 
cycling chemicals, Br J Cancer Suppl 8 (1987) 46-52. 
[19] K.E. Sant, J.M. Hansen, L.M. Williams, N.L. Tran, J.V. Goldstone, J.J. Stegeman, 
M.E. Hahn, A. Timme-Laragy, The role of Nrf1 and Nrf2 in the regulation of 
glutathione and redox dynamics in the developing zebrafish embryo, Redox Biol 
13 (2017) 207-218. 
[20] A.R. Timme-Laragy, J.V. Goldstone, B.R. Imhoff, J.J. Stegeman, M.E. Hahn, J.M. 
Hansen, Glutathione redox dynamics and expression of glutathione-related genes 
in the developing embryo, Free Radic Biol Med 65 (2013) 89-101. 
[21] C. Harris, D.Z. Shuster, R. Roman Gomez, K.E. Sant, M.S. Reed, J. Pohl, J.M. 
Hansen, Inhibition of glutathione biosynthesis alters compartmental redox status 
and the thiol proteome in organogenesis-stage rat conceptuses, Free Radic Biol 
Med 63 (2013) 325-37. 
[22] Z.Z. Shi, J. Osei-Frimpong, G. Kala, S.V. Kala, R.J. Barrios, G.M. Habib, D.J. 
Lukin, C.M. Danney, M.M. Matzuk, M.W. Lieberman, Glutathione synthesis is 
essential for mouse development but not for cell growth in culture, Proc Natl 
Acad Sci U S A 97(10) (2000) 5101-6. 
[23] Y. Will, K.A. Fischer, R.A. Horton, R.S. Kaetzel, M.K. Brown, O. Hedstrom, M.W. 
Lieberman, D.J. Reed, gamma-glutamyltranspeptidase-deficient knockout mice as 
a model to study the relationship between glutathione status, mitochondrial 
function, and cellular function, Hepatology 32(4 Pt 1) (2000) 740-9. 
[24] G. Filomeni, G. Rotilio, M.R. Ciriolo, Disulfide relays and phosphorylative 
cascades: partners in redox-mediated signaling pathways, Cell death and 
differentiation 12(12) (2005) 1555-63. 
	
	 130 
[25] P. Ghezzi, Protein glutathionylation in health and disease, Biochim Biophys Acta 
1830(5) (2013) 3165-72. 
[26] T. Nguyen, P. Nioi, C.B. Pickett, The Nrf2-antioxidant response element signaling 
pathway and its activation by oxidative stress, The Journal of biological chemistry 
284(20) (2009) 13291-5. 
[27] A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, 
M. Yamamoto, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-
based E3 ligase to regulate proteasomal degradation of Nrf2, Mol Cell Biol 
24(16) (2004) 7130-9. 
[28] K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, M. Yamamoto, 
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 
through binding to the amino-terminal Neh2 domain, Genes Dev 13(1) (1999) 76-
86. 
[29] D.D. Zhang, M. Hannink, Distinct cysteine residues in Keap1 are required for 
Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by 
chemopreventive agents and oxidative stress, Mol Cell Biol 23(22) (2003) 8137-
51. 
[30] Q. Ma, Role of nrf2 in oxidative stress and toxicity, Annu Rev Pharmacol Toxicol 
53 (2013) 401-26. 
[31] K. Mukaigasa, L.T. Nguyen, L. Li, H. Nakajima, M. Yamamoto, M. Kobayashi, 
Genetic Evidence of an Evolutionarily Conserved Role for Nrf2 in the Protection 
against Oxidative Stress, Molecular and Cellular Biology 32(21) (2012) 4455-61. 
[32] K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. 
Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, Y. Nabeshima, An Nrf2/small 
Maf heterodimer mediates the induction of phase II detoxifying enzyme genes 
through antioxidant response elements, Biochem Biophys Res Commun 236(2) 
(1997) 313-22. 
[33] A. Anwar-Mohamed, O.S. Degenhardt, M.A. El Gendy, J.M. Seubert, S.R. 
Kleeberger, A.O. El-Kadi, The effect of Nrf2 knockout on the constitutive 
expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers, 
Toxicol In Vitro 25(4) (2011) 785-95. 
[34] Y. Tanaka, L.M. Aleksunes, R.L. Yeager, M.A. Gyamfi, N. Esterly, G.L. Guo, C.D. 
Klaassen, NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress 
in mice fed a high-fat diet, The Journal of pharmacology and experimental 
therapeutics 325(2) (2008) 655-64. 
[35] K.N. Lewis, J. Mele, J.D. Hayes, R. Buffenstein, Nrf2, a Guardian of Healthspan 




[36] M.A. Furnari, C.L. Saw, A.N. Kong, G.C. Wagner, Altered behavioral development 
in Nrf2 knockout mice following early postnatal exposure to valproic acid, Brain 
research bulletin 109 (2014) 132-42. 
[37] A. Ramkissoon, P.G. Wells, Developmental role of nuclear factor E2-related factor 2 
in mitigating methamphetamine fetal toxicity and postnatal neurodevelopmental 
deficits, Free Radic Biol Med 65 (2013) 620-31. 
[38] N. Wakabayashi, K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, S. Takahashi, S. 
Imakado, T. Kotsuji, F. Otsuka, D.R. Roop, T. Harada, J.D. Engel, M. 
Yamamoto, Keap1-null mutation leads to postnatal lethality due to constitutive 
Nrf2 activation, Nat Genet 35(3) (2003) 238-45. 
[39] C.N. Hales, D.J. Barker, Type 2 (non-insulin-dependent) diabetes mellitus: the 
thrifty phenotype hypothesis, Diabetologia 35(7) (1992) 595-601. 
[40] M.W. Gillman, Developmental origins of health and disease, The New England 
journal of medicine 353(17) (2005) 1848-50. 
[41] P.D. Wadhwa, C. Buss, S. Entringer, J.M. Swanson, Developmental origins of health 
and disease: brief history of the approach and current focus on epigenetic 
mechanisms, Semin Reprod Med 27(5) (2009) 358-68. 
[42] J.M. Hansen, C. Harris, A novel hypothesis for thalidomide-induced limb 
teratogenesis: redox misregulation of the NF-kappaB pathway, Antioxidants & 
redox signaling 6(1) (2004) 1-14. 
[43] J.M. Hansen, S.G. Gong, M. Philbert, C. Harris, Misregulation of gene expression in 
the redox-sensitive NF-kappab-dependent limb outgrowth pathway by 
thalidomide, Dev Dyn 225(2) (2002) 186-94. 
[44] P.G. Wells, Y. Bhuller, C.S. Chen, W. Jeng, S. Kasapinovic, J.C. Kennedy, P.M. 
Kim, R.R. Laposa, G.P. McCallum, C.J. Nicol, T. Parman, M.J. Wiley, A.W. 
Wong, Molecular and biochemical mechanisms in teratogenesis involving 
reactive oxygen species, Toxicol Appl Pharmacol 207(2 Suppl) (2005) 354-66. 
[45] S. Bhatia, D.M. Drake, L. Miller, P.G. Wells, Oxidative stress and DNA damage in 
the mechanism of fetal alcohol spectrum disorders, Birth Defects Res 111(12) 
(2019) 714-748. 
[46] A.R. Ji, S.Y. Ku, M.S. Cho, Y.Y. Kim, Y.J. Kim, S.K. Oh, S.H. Kim, S.Y. Moon, 
Y.M. Choi, Reactive oxygen species enhance differentiation of human embryonic 
stem cells into mesendodermal lineage, Exp Mol Med 42(3) (2010) 175-86. 
[47] M. Barandalla, S. Colleoni, G. Lazzari, Differential Response of Human Embryonic 
Stem and Somatic Cells to Non-Cytotoxic Hydrogen Peroxide Exposure: An 
Attempt to Model In Vitro the Effects of Oxidative Stress on the Early Embryo, 
Cell Dev Biol 5(2) (2016). 
	
	 132 
[48] D.P. Jones, Y. Liang, Measuring the poise of thiol/disulfide couples in vivo, Free 
Radic Biol Med 47(10) (2009) 1329-38. 
[49] D.P. Jones, J.L. Carlson, V.C. Mody, J. Cai, M.J. Lynn, P. Sternberg, Redox state of 
glutathione in human plasma, Free Radic Biol Med 28(4) (2000) 625-35. 
[50] Y. Fujitani, Transcriptional regulation of pancreas development and beta-cell 
function [Review], Endocrine journal  (2017). 
[51] H.L. Larsen, A. Grapin-Botton, The molecular and morphogenetic basis of pancreas 
organogenesis, Semin Cell Dev Biol  (2017). 
[52] H.E. Arda, C.M. Benitez, S.K. Kim, Gene regulatory networks governing pancreas 
development, Developmental cell 25(1) (2013) 5-13. 
[53] J.N. Ham, D.A. Stoffers, Role of Pdx-1 in B-cell Growth, in: R.N. Kulkarni (Ed.), 
Islet Cell Growth Factors, Landis Bioscience2011, pp. 39-56. 
[54] Y. Fujitani, S. Fujitani, D.F. Boyer, M. Gannon, Y. Kawaguchi, M. Ray, M. Shiota, 
R.W. Stein, M.A. Magnuson, C.V. Wright, Targeted deletion of a cis-regulatory 
region reveals differential gene dosage requirements for Pdx1 in foregut organ 
differentiation and pancreas formation, Genes Dev 20(2) (2006) 253-66. 
[55] H. Kaneto, G. Xu, N. Fujii, S. Kim, S. Bonner-Weir, G.C. Weir, Involvement of c-
Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene 
expression, The Journal of biological chemistry 277(33) (2002) 30010-8. 
[56] R.P. Robertson, J. Harmon, P.O. Tran, Y. Tanaka, H. Takahashi, Glucose toxicity in 
beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione 
connection, Diabetes 52(3) (2003) 581-7. 
[57] K.E. Sant, H.M. Jacobs, L.G. Moss, J.B. Moss, A.R. Timme-Laragy, Assessment of 
toxicological perturbations and variants of pancreatic islet development in the 
zebrafish model, Toxics 4(3) (2016) 20. 
[58] E. Hoarau, V. Chandra, P. Rustin, R. Scharfmann, B. Duvillie, Pro-
oxidant/antioxidant balance controls pancreatic beta-cell differentiation through 
the ERK1/2 pathway, Cell death & disease 5 (2014) e1487. 
[59] M. Rovira, W. Huang, S. Yusuff, J.S. Shim, A.A. Ferrante, J.O. Liu, M.J. Parsons, 
Chemical screen identifies FDA-approved drugs and target pathways that induce 
precocious pancreatic endocrine differentiation, Proc Natl Acad Sci U S A 
108(48) (2011) 19264-9. 
[60] E. Fernandez, M.A. Martin, S. Fajardo, F. Escriva, C. Alvarez, Increased IRS-2 
content and activation of IGF-I pathway contribute to enhance beta-cell mass in 
fetuses from undernourished pregnant rats, American journal of physiology. 
Endocrinology and metabolism 292(1) (2007) E187-95. 
	
	 133 
[61] C. Leloup, C. Tourrel-Cuzin, C. Magnan, M. Karaca, J. Castel, L. Carneiro, A.-L. 
Colombani, A. Ktorza, L. Casteilla, L. Pénicaud, Mitochondrial Reactive Oxygen 
Species Are Obligatory Signals for Glucose-Induced Insulin Secretion, Diabetes 
58(3) (2009) 673-681. 
[62] J. Fu, Q. Cui, B. Yang, Y. Hou, H. Wang, Y. Xu, D. Wang, Q. Zhang, J. Pi, The 
impairment of glucose-stimulated insulin secretion in pancreatic beta-cells caused 
by prolonged glucotoxicity and lipotoxicity is associated with elevated adaptive 
antioxidant response, Food and chemical toxicology : an international journal 
published for the British Industrial Biological Research Association 100 (2017) 
161-167. 
[63] H. Kaneto, D. Kawamori, Y. Nakatani, S. Gorogawa, T.A. Matsuoka, Oxidative 
stress and the JNK pathway as a potential therapeutic target for diabetes, Drug 
news & perspectives 17(7) (2004) 447-53. 
[64] J. Fu, Q. Zhang, C.G. Woods, H. Zheng, B. Yang, W. Qu, M.E. Andersen, J. Pi, 
Divergent effects of sulforaphane on basal and glucose-stimulated insulin 
secretion in beta-cells: role of reactive oxygen species and induction of 
endogenous antioxidants, Pharmaceutical research 30(9) (2013) 2248-59. 
[65] J.P. McClung, C.A. Roneker, W. Mu, D.J. Lisk, P. Langlais, F. Liu, X.G. Lei, 
Development of insulin resistance and obesity in mice overexpressing cellular 
glutathione peroxidase, Proc Natl Acad Sci U S A 101(24) (2004) 8852-7. 
[66] X. Li, H. Chen, P.N. Epstein, Metallothionein and catalase sensitize to diabetes in 
nonobese diabetic mice: reactive oxygen species may have a protective role in 
pancreatic beta-cells, Diabetes 55(6) (2006) 1592-604. 
[67] L.M. Aleksunes, S.A. Reisman, R.L. Yeager, M.J. Goedken, C.D. Klaassen, Nuclear 
factor erythroid 2-related factor 2 deletion impairs glucose tolerance and 
exacerbates hyperglycemia in type 1 diabetic mice, The Journal of pharmacology 
and experimental therapeutics 333(1) (2010) 140-51. 
[68] J. Xu, S.R. Kulkarni, A.C. Donepudi, V.R. More, A.L. Slitt, Enhanced Nrf2 activity 
worsens insulin resistance, impairs lipid accumulation in adipose tissue, and 
increases hepatic steatosis in leptin-deficient mice, Diabetes 61(12) (2012) 3208-
18. 
[69] Y. Yagishita, T. Fukutomi, A. Sugawara, H. Kawamura, T. Takahashi, J. Pi, A. 
Uruno, M. Yamamoto, Nrf2 Protects Pancreatic beta-Cells from Oxidative and 
Nitrosative Stress in Diabetic Model Mice, Diabetes  (2013). 
[70] A. Uruno, Y. Furusawa, Y. Yagishita, T. Fukutomi, H. Muramatsu, T. Negishi, A. 
Sugawara, T.W. Kensler, M. Yamamoto, The Keap1-Nrf2 system prevents onset 
of diabetes mellitus, Mol Cell Biol 33(15) (2013) 2996-3010. 
	
	 134 
[71] K.E. Sant, H.M. Jacobs, K.A. Borofski, J.B. Moss, A.R. Timme-Laragy, Embryonic 
exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic 
organogenesis in the zebrafish, Danio rerio, Environ Pollut 220(Pt B) (2017) 807-
817. 
[72] K.E. Sant, P.P. Sinno, H.M. Jacobs, A.R. Timme-Laragy, Nrf2a modulates the 
embryonic antioxidant response to perfluorooctanesulfonic acid (PFOS) in the 
zebrafish, Danio rerio, Aquat Toxicol 198 (2018) 92-102. 
[73] A.R. Timme-Laragy, K.E. Sant, M.E. Rousseau, P.J. diIorio, Deviant development 
of pancreatic beta cells from embryonic exposure to PCB-126 in zebrafish, Comp 
Biochem Physiol C Toxicol Pharmacol 178 (2015) 25-32. 
[74] H.M. Jacobs, K.E. Sant, A. Basnet, L.M. Williams, J.B. Moss, A.R. Timme-Laragy, 
Embryonic exposure to Mono(2-ethylhexyl) phthalate (MEHP) disrupts 
pancreatic organogenesis in zebrafish (Danio rerio), Chemosphere 195 (2018) 
498-507. 
[75] S.E. Brown, K.E. Sant, S.M. Fleischman, O. Venezia, M.A. Roy, L. Zhao, A.R. 
Timme-Laragy, Pancreatic beta cells are a sensitive target of embryonic exposure 
to butylparaben in zebrafish (Danio rerio), Birth Defects Res 110(11) (2018) 933-
948. 
[76] A. Rastogi, C.W. Clark, S.M. Conlin, S.E. Brown, A.R. Timme-Laragy, Mapping 
glutathione utilization in the developing zebrafish (Danio rerio) embryo, Redox 
Biol 26 (2019) 101235. 
[77] J.M. Hansen, E.W. Carney, C. Harris, Altered differentiation in rat and rabbit limb 
bud micromass cultures by glutathione modulating agents, Free Radic Biol Med 
31(12) (2001) 1582-92. 
[78] H. Choe, J.M. Hansen, C. Harris, Spatial and temporal ontogenies of glutathione 
peroxidase and glutathione disulfide reductase during development of the prenatal 
rat, J Biochem Mol Toxicol 15(4) (2001) 197-206. 
[79] B.R. Imhoff, J.M. Hansen, Extracellular redox environments regulate adipocyte 
differentiation, Differentiation; research in biological diversity 80(1) (2010) 31-9. 
[80] B.R. Imhoff, J.M. Hansen, Differential redox potential profiles during adipogenesis 
and osteogenesis, Cellular & molecular biology letters 16(1) (2011) 149-61. 
[81] L.P. Thompson, Y. Al-Hasan, Impact of Oxidative Stress in Fetal Programming, 
Journal of Pregnancy 2012 (2012) 8. 
[82] J. de Faria Poloni, H. Chapola, B.C. Feltes, D. Bonatto, The importance of 
sphingolipids and reactive oxygen species in cardiovascular development, 
Biology of the cell 106(6) (2014) 167-81. 
	
	 135 
[83] J. Smith, E. Ladi, M. Mayer-Proschel, M. Noble, Redox state is a central modulator 
of the balance between self-renewal and differentiation in a dividing glial 
precursor cell, Proc Natl Acad Sci U S A 97(18) (2000) 10032-7. 
[84] D.P. Jones, Redefining oxidative stress, Antioxidants & redox signaling 8(9-10) 
(2006) 1865-79. 
[85] W.G. Kirlin, J. Cai, S.A. Thompson, D. Diaz, T.J. Kavanagh, D.P. Jones, 
Glutathione redox potential in response to differentiation and enzyme inducers, 
Free Radic Biol Med 27(11-12) (1999) 1208-18. 
[86] Y.S. Nkabyo, T.R. Ziegler, L.H. Gu, W.H. Watson, D.P. Jones, Glutathione and 
thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells, 
American journal of physiology. Gastrointestinal and liver physiology 283(6) 
(2002) G1352-9. 
[87] D.P. Jones, Redox potential of GSH/GSSG couple: assay and biological 
significance, Methods in enzymology 348 (2002) 93-112. 
[88] R.F. Leite, K. Annes, J. Ispada, C.B. de Lima, E.C. Dos Santos, P.K. Fontes, M.F.G. 
Nogueira, M.P. Milazzotto, Oxidative Stress Alters the Profile of Transcription 
Factors Related to Early Development on In Vitro Produced Embryos, Oxid Med 
Cell Longev 2017 (2017) 1502489. 
[89] M.E. Rousseau, K.E. Sant, L.R. Borden, D.G. Franks, M.E. Hahn, A.R. Timme-
Laragy, Regulation of Ahr signaling by Nrf2 during development: Effects of 
Nrf2a deficiency on PCB126 embryotoxicity in zebrafish (Danio rerio), Aquat 
Toxicol 167 (2015) 157-71. 
[90] J.M. Hansen, C. Harris, Redox control of teratogenesis, Reprod Toxicol 35 (2013) 
165-79. 
[91] C. Harris, J.M. Hansen, Nrf2-mediated resistance to oxidant-induced redox 
disruption in embryos, Birth Defects Res B Dev Reprod Toxicol 95(3) (2012) 
213-8. 
[92] A. Tierbach, K.J. Groh, R. Schonenberger, K. Schirmer, M.J. Suter, Glutathione S-
Transferase Protein Expression in Different Life Stages of Zebrafish (Danio 
rerio), Toxicol Sci 162(2) (2018) 702-712. 
[93] J.D. Hayes, D.J. Pulford, The glutathione S-transferase supergene family: regulation 
of GST and the contribution of the isoenzymes to cancer chemoprotection and 
drug resistance, Crit Rev Biochem Mol Biol 30(6) (1995) 445-600. 
[94] S. Landi, Mammalian class theta GST and differential susceptibility to carcinogens: 
a review, Mutat Res 463(3) (2000) 247-83. 
	
	 136 
[95] J.M. Hansen, Oxidative stress as a mechanism of teratogenesis, Birth Defects Res C 
Embryo Today 78(4) (2006) 293-307. 
[96] R. Meunier, Stages in the development of a model organism as a platform for 
mechanistic models in developmental biology: Zebrafish, 1970-2000, Stud Hist 
Philos Biol Biomed Sci 43(2) (2012) 522-31. 
[97] M.B. Veldman, S. Lin, Zebrafish as a developmental model organism for pediatric 
research, Pediatr Res 64(5) (2008) 470-6. 
[98] A.J. Hill, H. Teraoka, W. Heideman, R.E. Peterson, Zebrafish as a model vertebrate 
for investigating chemical toxicity, Toxicol Sci 86(1) (2005) 6-19. 
[99] Y.J. Dai, Y.F. Jia, N. Chen, W.P. Bian, Q.K. Li, Y.B. Ma, Y.L. Chen, D.S. Pei, 
Zebrafish as a model system to study toxicology, Environ Toxicol Chem 33(1) 
(2014) 11-7. 
[100] L. Swain, M.S. Nanadikar, S. Borowik, A. Zieseniss, D.M. Katschinski, Transgenic 
Organisms Meet Redox Bioimaging: One Step Closer to Physiology, Antioxidants 
& redox signaling 29(6) (2018) 603-612. 
[101] X. Zhao, K. Lorent, B.J. Wilkins, D.M. Marchione, K. Gillespie, O. Waisbourd-
Zinman, J. So, K.A. Koo, D. Shin, J.R. Porter, R.G. Wells, I. Blair, M. Pack, 
Glutathione antioxidant pathway activity and reserve determine toxicity and 
specificity of the biliary toxin biliatresone in zebrafish, Hepatology 64(3) (2016) 
894-907. 
[102] E. Panieri, C. Millia, M.M. Santoro, Real-time quantification of subcellular H2O2 
and glutathione redox potential in living cardiovascular tissues, Free Radical 
Biology and Medicine  (2017). 
[103] B. Kalyanaraman, V. Darley-Usmar, K.J. Davies, P.A. Dennery, H.J. Forman, M.B. 
Grisham, G.E. Mann, K. Moore, L.J. Roberts, 2nd, H. Ischiropoulos, Measuring 
reactive oxygen and nitrogen species with fluorescent probes: challenges and 
limitations, Free Radic Biol Med 52(1) (2012) 1-6. 
[104] H. Kamencic, A. Lyon, P.G. Paterson, B.H. Juurlink, Monochlorobimane 
fluorometric method to measure tissue glutathione, Anal Biochem 286(1) (2000) 
35-7. 
[105] T. Lorincz, A. Szarka, The determination of hepatic glutathione at tissue and 
subcellular level, J Pharmacol Toxicol Methods 88(Pt 1) (2017) 32-39. 
[106] S. Keshavarzi, M. Salehi, F. Farifteh-Nobijari, T. Hosseini, S. Hosseini, A. 
Ghazifard, M. Ghaffari Novin, V. Fallah-Omrani, M. Nourozian, A. Hosseini, 
Melatonin Modifies Histone Acetylation During In Vitro Maturation of Mouse 
Oocytes, Cell J 20(2) (2018) 244-249. 
	
	 137 
[107] M. Narasimhan, M. Rathinam, D. Patel, G. Henderson, L. Mahimainathan, 
Astrocytes Prevent Ethanol Induced Apoptosis of Nrf2 Depleted Neurons by 
Maintaining GSH Homeostasis, Open J Apoptosis 1(2) (2012). 
[108] G. Bellomo, M. Vairetti, L. Stivala, F. Mirabelli, P. Richelmi, S. Orrenius, 
Demonstration of nuclear compartmentalization of glutathione in hepatocytes, 
Proc Natl Acad Sci U S A 89(10) (1992) 4412-6. 
[109] A. Jos, A.M. Camean, S. Pflugmacher, H. Segner, The antioxidant glutathione in 
the fish cell lines EPC and BCF-2: response to model pro-oxidants as measured 
by three different fluorescent dyes, Toxicol In Vitro 23(3) (2009) 546-53. 
[110] J. Sebastia, R. Cristofol, M. Martin, E. Rodriguez-Farre, C. Sanfeliu, Evaluation of 
fluorescent dyes for measuring intracellular glutathione content in primary 
cultures of human neurons and neuroblastoma SH-SY5Y, Cytometry A 51(1) 
(2003) 16-25. 
[111] B. Glisic, I. Mihaljevic, M. Popovic, R. Zaja, J. Loncar, K. Fent, R. Kovacevic, T. 
Smital, Characterization of glutathione-S-transferases in zebrafish (Danio rerio), 
Aquat Toxicol 158 (2015) 50-62. 
[112] C.B. Kimmel, W.W. Ballard, S.R. Kimmel, B. Ullmann, T.F. Schilling, Stages of 
embryonic development of the zebrafish, Dev Dyn 203(3) (1995) 253-310. 
[113] C.Y. Usenko, S.L. Harper, R.L. Tanguay, Fullerene C60 exposure elicits an 
oxidative stress response in embryonic zebrafish, Toxicol Appl Pharmacol 229(1) 
(2008) 44-55. 
[114] A.R. Timme-Laragy, L.A. Van Tiem, E.A. Linney, R.T. Di Giulio, Antioxidant 
responses and NRF2 in synergistic developmental toxicity of PAHs in zebrafish, 
Toxicol Sci 109(2) (2009) 217-27. 
[115] W. Zhai, Z. Huang, L. Chen, C. Feng, B. Li, T. Li, Thyroid endocrine disruption in 
zebrafish larvae after exposure to mono-(2-ethylhexyl) phthalate (MEHP), PLoS 
One 9(3) (2014) e92465. 
[116] A. Gorlach, K. Bertram, S. Hudecova, O. Krizanova, Calcium and ROS: A mutual 
interplay, Redox Biol 6 (2015) 260-71. 
[117] OECD, Test No. 236: Fish Embryo Acute Toxicity (FET) Test, 2013. 
[118] V. Korzh, Development of brain ventricular system, Cell Mol Life Sci 75(3) (2018) 
375-383. 
[119] M. Samuelsson, L. Vainikka, K. Ollinger, Glutathione in the blood and 




[120] A. Fleming, H. Diekmann, P. Goldsmith, Functional characterisation of the 
maturation of the blood-brain barrier in larval zebrafish, PLoS One 8(10) (2013) 
e77548. 
[121] D. Sheehan, G. Meade, V.M. Foley, C.A. Dowd, Structure, function and evolution 
of glutathione transferases: implications for classification of non-mammalian 
members of an ancient enzyme superfamily, Biochem J 360(Pt 1) (2001) 1-16. 
[122] B. Glisic, J. Hrubik, S. Fa, N. Dopudj, R. Kovacevic, N. Andric, Transcriptional 
profiles of glutathione-S-Transferase isoforms, Cyp, and AOE genes in atrazine-
exposed zebrafish embryos, Environ Toxicol 31(2) (2016) 233-44. 
[123] M.S. Abunnaja, K. Kurogi, Y.I. Mohammed, Y. Sakakibara, M. Suiko, E.A. 
Hassoun, M.C. Liu, Identification and characterization of the zebrafish 
glutathione S-transferase Pi-1, J Biochem Mol Toxicol 31(10) (2017). 
[124] J. Bakkers, Zebrafish as a model to study cardiac development and human cardiac 
disease, Cardiovasc Res 91(2) (2011) 279-88. 
[125] D.Y. Stainier, R.K. Lee, M.C. Fishman, Cardiovascular development in the 
zebrafish. I. Myocardial fate map and heart tube formation, Development 119(1) 
(1993) 31-40. 
[126] M.T. Raijmakers, E.A. Steegers, W.H. Peters, Glutathione S-transferases and thiol 
concentrations in embryonic and early fetal tissues, Hum Reprod 16(11) (2001) 
2445-50. 
[127] J. Chu, K.C. Sadler, New school in liver development: lessons from zebrafish, 
Hepatology 50(5) (2009) 1656-63. 
[128] B.J. Wilkins, M. Pack, Zebrafish models of human liver development and disease, 
Compr Physiol 3(3) (2013) 1213-30. 
[129] C. Ufer, C.C. Wang, The Roles of Glutathione Peroxidases during Embryo 
Development, Frontiers in molecular neuroscience 4 (2011) 12. 
[130] C.S. Gardiner, D.J. Reed, Synthesis of glutathione in the preimplantation mouse 
embryo, Archives of biochemistry and biophysics 318(1) (1995) 30-6. 
[131] C.S. Gardiner, D.J. Reed, Status of glutathione during oxidant-induced oxidative 
stress in the preimplantation mouse embryo, Biol Reprod 51(6) (1994) 1307-14. 
[132] R. Dringen, L. Kussmaul, B. Hamprecht, Detoxification of exogenous hydrogen 
peroxide and organic hydroperoxides by cultured astroglial cells assessed by 
microtiter plate assay, Brain Res Brain Res Protoc 2(3) (1998) 223-8. 
[133] D. Ross, H. Thor, S. Orrenius, P. Moldeus, Interaction of menadione (2-methyl-
1,4-naphthoquinone) with glutathione, Chem Biol Interact 55(1-2) (1985) 177-84. 
	
	 139 
[134] T.J. Chiou, W.F. Tzeng, The roles of glutathione and antioxidant enzymes in 
menadione-induced oxidative stress, Toxicology 154(1-3) (2000) 75-84. 
[135] C.L. Bladen, D.J. Kozlowski, W.S. Dynan, Effects of low-dose ionizing radiation 
and menadione, an inducer of oxidative stress, alone and in combination in a 
vertebrate embryo model, Radiat Res 178(5) (2012) 499-503. 
[136] S. Awasthi, S.K. Srivastava, F. Ahmad, H. Ahmad, G.A. Ansari, Interactions of 
glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate, 
Biochim Biophys Acta 1164(2) (1993) 173-8. 
[137] J.H. Ploemen, B. van Ommen, J.J. Bogaards, P.J. van Bladeren, Ethacrynic acid 
and its glutathione conjugate as inhibitors of glutathione S-transferases, 
Xenobiotica 23(8) (1993) 913-23. 
[138] J.H. Ploemen, J.J. Bogaards, G.A. Veldink, B. van Ommen, D.H. Jansen, P.J. van 
Bladeren, Isoenzyme selective irreversible inhibition of rat and human glutathione 
S-transferases by ethacrynic acid and two brominated derivatives, Biochem 
Pharmacol 45(3) (1993) 633-9. 
[139] D.W. Hedley, S. Chow, Evaluation of methods for measuring cellular glutathione 
content using flow cytometry, Cytometry 15(4) (1994) 349-58. 
[140] G.C. Rice, E.A. Bump, D.C. Shrieve, W. Lee, M. Kovacs, Quantitative analysis of 
cellular glutathione by flow cytometry utilizing monochlorobimane: some 
applications to radiation and drug resistance in vitro and in vivo, Cancer Res 
46(12 Pt 1) (1986) 6105-10. 
[141] G.A. Ublacker, J.A. Johnson, F.L. Siegel, R.T. Mulcahy, Influence of glutathione 
S-transferases on cellular glutathione determination by flow cytometry using 
monochlorobimane, Cancer Res 51(7) (1991) 1783-8. 
[142] J.M. Hansen, E.W. Carney, C. Harris, Differential alteration by thalidomide of the 
glutathione content of rat vs. rabbit conceptuses in vitro, Reprod Toxicol 13(6) 
(1999) 547-54. 
[143] D.J. Barker, C. Osmond, Infant mortality, childhood nutrition, and ischaemic heart 
disease in England and Wales, Lancet 1(8489) (1986) 1077-81. 
[144] R. Dumollard, Z. Ward, J. Carroll, M.R. Duchen, Regulation of redox metabolism 
in the mouse oocyte and embryo, Development 134(3) (2007) 455-65. 
[145] N. Liu, L. Jiang, X. Sun, X. Yao, X. Zhai, X. Liu, X. Wu, Y. Bai, S. Wang, G. 
Yang, Mono-(2-ethylhexyl) phthalate induced ROS-dependent autophagic cell 
death in human vascular endothelial cells, Toxicol In Vitro 44 (2017) 49-56. 
	
	 140 
[146] W. Wang, Z.R. Craig, M.S. Basavarajappa, K.S. Hafner, J.A. Flaws, Mono-(2-
ethylhexyl) phthalate induces oxidative stress and inhibits growth of mouse 
ovarian antral follicles, Biol Reprod 87(6) (2012) 152. 
[147] G. Roeselers, E.K. Mittge, W.Z. Stephens, D.M. Parichy, C.M. Cavanaugh, K. 
Guillemin, J.F. Rawls, Evidence for a core gut microbiota in the zebrafish, ISME 
J 5(10) (2011) 1595-608. 
[148] W.Z. Stephens, A.R. Burns, K. Stagaman, S. Wong, J.F. Rawls, K. Guillemin, B.J. 
Bohannan, The composition of the zebrafish intestinal microbial community 
varies across development, ISME J 10(3) (2016) 644-54. 
[149] J. Chen, S.R. Das, J. La Du, M.M. Corvi, C. Bai, Y. Chen, X. Liu, G. Zhu, R.L. 
Tanguay, Q. Dong, C. Huang, Chronic PFOS exposures induce life stage-specific 
behavioral deficits in adult zebrafish and produce malformation and behavioral 
deficits in F1 offspring, Environ Toxicol Chem 32(1) (2013) 201-6. 
[150] C.E. Jantzen, K.M. Annunziato, K.R. Cooper, Behavioral, morphometric, and gene 
expression effects in adult zebrafish (Danio rerio) embryonically exposed to 
PFOA, PFOS, and PFNA, Aquat Toxicol 180 (2016) 123-130. 
[151] I.G. Ryoo, H. Ha, M.K. Kwak, Inhibitory role of the KEAP1-NRF2 pathway in 
TGFbeta1-stimulated renal epithelial transition to fibroblastic cells: a modulatory 
effect on SMAD signaling, PLoS One 9(4) (2014) e93265. 
[152] S. Arfmann-Knubel, B. Struck, G. Genrich, O. Helm, B. Sipos, S. Sebens, H. 
Schafer, The Crosstalk between Nrf2 and TGF-beta1 in the Epithelial-
Mesenchymal Transition of Pancreatic Duct Epithelial Cells, PLoS One 10(7) 
(2015) e0132978. 
[153] T. Yano, M. Oku, N. Akeyama, A. Itoyama, H. Yurimoto, S. Kuge, Y. Fujiki, Y. 
Sakai, A Novel Fluorescent Sensor Protein for Visualization of Redox States in 
the Cytoplasm and in Peroxisomes, Molecular and Cellular Biology 30(15) (2010) 
3758-3766. 
[154] M. Gutscher, A.L. Pauleau, L. Marty, T. Brach, G.H. Wabnitz, Y. Samstag, A.J. 
Meyer, T.P. Dick, Real-time imaging of the intracellular glutathione redox 
potential, Nat Methods 5(6) (2008) 553-9. 
[155] C. Cossetti, G. Di Giovamberardino, R. Rota, A. Pastore, Pitfalls in the quantitative 
imaging of glutathione in living cells, Nature communications 9(1) (2018) 1588. 
[156] A.D. Association, Economic Costs of Diabetes in the U.S. in 2017, Diabetes Care 
41(5) (2018) 917-928. 
[157] F.C. Pan, M. Brissova, Pancreas development in humans, Curr Opin Endocrinol 
Diabetes Obes 21(2) (2014) 77-82. 
	
	 141 
[158] K.E. Sant, H.M. Jacobs, J. Xu, K.A. Borofski, L.G. Moss, J.B. Moss, A.R. Timme-
Laragy, Assessment of Toxicological Perturbations and Variants of Pancreatic 
Islet Development in the Zebrafish Model, Toxics 4(3) (2016). 
[159] J. Pi, Y. Bai, Q. Zhang, V. Wong, L.M. Floering, K. Daniel, J.M. Reece, J.T. 
Deeney, M.E. Andersen, B.E. Corkey, S. Collins, Reactive oxygen species as a 
signal in glucose-stimulated insulin secretion, Diabetes 56(7) (2007) 1783-91. 
[160] A. Miki, C. Ricordi, Y. Sakuma, T. Yamamoto, R. Misawa, A. Mita, R.D. Molano, 
N.D. Vaziri, A. Pileggi, H. Ichii, Divergent antioxidant capacity of human islet 
cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet 
transplantation, PLoS One 13(5) (2018) e0196570. 
[161] A. Meister, Glutathione metabolism and its selective modification, The Journal of 
biological chemistry 263(33) (1988) 17205-8. 
[162] N. Tiso, E. Moro, F. Argenton, Zebrafish pancreas development, Mol Cell 
Endocrinol 312(1-2) (2009) 24-30. 
[163] R. Brigelius-Flohe, L. Flohe, Basic principles and emerging concepts in the redox 
control of transcription factors, Antioxidants & redox signaling 15(8) (2011) 
2335-81. 
[164] K. Dominko, D. Dikic, Glutathionylation: a regulatory role of glutathione in 
physiological processes, Arh Hig Rada Toksikol 69(1) (2018) 1-24. 
[165] M.B. Sporn, K.T. Liby, NRF2 and cancer: the good, the bad and the importance of 
context, Nat Rev Cancer 12(8) (2012) 564-71. 
[166] M. Rojo de la Vega, E. Chapman, D.D. Zhang, NRF2 and the Hallmarks of Cancer, 
Cancer Cell 34(1) (2018) 21-43. 
[167] M.E. Hahn, A.R. Timme-Laragy, S.I. Karchner, J.J. Stegeman, Nrf2 and Nrf2-
related proteins in development and developmental toxicity: Insights from studies 
in zebrafish (Danio rerio), Free Radic Biol Med 88(Pt B) (2015) 275-289. 
[168] L.M. Williams, A.R. Timme-Laragy, J.V. Goldstone, A.G. McArthur, J.J. 
Stegeman, R.M. Smolowitz, M.E. Hahn, Developmental expression of the Nfe2-
related factor (Nrf) transcription factor family, PLoS ONE 8(10) (2013) e79574. 
[169] P.A. Gerber, G.A. Rutter, The Role of Oxidative Stress and Hypoxia in Pancreatic 
Beta-Cell Dysfunction in Diabetes Mellitus, Antioxidants & redox signaling 
26(10) (2017) 501-518. 
[170] A.R. Timme-Laragy, S.I. Karchner, D.G. Franks, M.J. Jenny, R.C. Harbeitner, J.V. 
Goldstone, A.G. McArthur, M.E. Hahn, Nrf2b: a novel zebrafish paralog of the 
oxidant-responsive transcription factor NF-E2-related factor 2 (NRF2), Journal of 
Biological Chemistry 287 (2012) 4609-4627. 
	
	 142 
[171] J.D. Hayes, A.T. Dinkova-Kostova, The Nrf2 regulatory network provides an 
interface between redox and intermediary metabolism, Trends in biochemical 
sciences 39(4) (2014) 199-218. 
[172] M. Alia, S. Ramos, R. Mateos, L. Bravo, L. Goya, Response of the antioxidant 
defense system to tert-butyl hydroperoxide and hydrogen peroxide in a human 
hepatoma cell line (HepG2), J Biochem Mol Toxicol 19(2) (2005) 119-28. 
[173] K. Koulajian, A. Ivovic, K. Ye, T. Desai, A. Shah, I.G. Fantus, Q. Ran, A. Giacca, 
Overexpression of glutathione peroxidase 4 prevents beta-cell dysfunction 
induced by prolonged elevation of lipids in vivo, American journal of physiology. 
Endocrinology and metabolism 305(2) (2013) E254-62. 
[174] J.S. Harmon, M. Bogdani, S.D. Parazzoli, S.S. Mak, E.A. Oseid, M. Berghmans, 
R.C. Leboeuf, R.P. Robertson, beta-Cell-specific overexpression of glutathione 
peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice, 
Endocrinology 150(11) (2009) 4855-62. 
[175] A.K. Rundlof, M. Carlsten, E.S. Arner, The core promoter of human thioredoxin 
reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding 
reveal a housekeeping-type promoter for the AU-rich element-regulated gene, The 
Journal of biological chemistry 276(32) (2001) 30542-51. 
[176] M.E. Hahn, A.G. McArthur, S.I. Karchner, D.G. Franks, M.J. Jenny, A.R. Timme-
Laragy, J.J. Stegeman, B.R. Woodin, M.J. Cipriano, E. Linney, The 
transcriptional response to oxidative stress during vertebrate development: effects 
of tert-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin, PLoS One 
9(11) (2014) e113158. 
[177] M.P. Mayer, B. Bukau, Hsp70 chaperones: cellular functions and molecular 
mechanism, Cell Mol Life Sci 62(6) (2005) 670-84. 
[178] R.J. Mailloux, A. Fu, C. Robson-Doucette, E.M. Allister, M.B. Wheeler, R. 
Screaton, M.E. Harper, Glutathionylation state of uncoupling protein-2 and the 
control of glucose-stimulated insulin secretion, The Journal of biological 
chemistry 287(47) (2012) 39673-85. 
[179] A.N. Carvalho, C. Marques, R.C. Guedes, M. Castro-Caldas, E. Rodrigues, J. van 
Horssen, M.J. Gama, S-Glutathionylation of Keap1: a new role for glutathione S-
transferase pi in neuronal protection, FEBS letters 590(10) (2016) 1455-66. 
[180] V. Adler, Z. Yin, S.Y. Fuchs, M. Benezra, L. Rosario, K.D. Tew, M.R. Pincus, M. 
Sardana, C.J. Henderson, C.R. Wolf, R.J. Davis, Z. Ronai, Regulation of JNK 
signaling by GSTp, EMBO J 18(5) (1999) 1321-34. 
[181] K. Fujimoto, K.S. Polonsky, Pdx1 and other factors that regulate pancreatic beta-
cell survival, Diabetes Obes Metab 11 Suppl 4 (2009) 30-7. 
	
	 143 
[182] D. Kawamori, Y. Kajimoto, H. Kaneto, Y. Umayahara, Y. Fujitani, T. Miyatsuka, 
H. Watada, I.B. Leibiger, Y. Yamasaki, M. Hori, Oxidative stress induces nucleo-
cytoplasmic translocation of pancreatic transcription factor PDX-1 through 
activation of c-Jun NH(2)-terminal kinase, Diabetes 52(12) (2003) 2896-904. 
[183] R.B. Sharma, A.C. O'Donnell, R.E. Stamateris, B. Ha, K.M. McCloskey, P.R. 
Reynolds, P. Arvan, L.C. Alonso, Insulin demand regulates beta cell number via 
the unfolded protein response, J Clin Invest 125(10) (2015) 3831-46. 
[184] M. Szabat, M.M. Page, E. Panzhinskiy, S. Skovso, M. Mojibian, J. Fernandez-
Tajes, J.E. Bruin, M.J. Bround, J.T. Lee, E.E. Xu, F. Taghizadeh, S. O'Dwyer, M. 
van de Bunt, K.M. Moon, S. Sinha, J. Han, Y. Fan, F.C. Lynn, M. Trucco, C.H. 
Borchers, L.J. Foster, C. Nislow, T.J. Kieffer, J.D. Johnson, Reduced Insulin 
Production Relieves Endoplasmic Reticulum Stress and Induces beta Cell 
Proliferation, Cell Metab 23(1) (2016) 179-93. 
[185] J. Edwards, C. Ackerman, A Review of Diabetes Mellitus and Exposure to the 
Environmental Toxicant Cadmium with an Emphasis on Likely Mechanisms of 
Action, Curr Diabetes Rev 12(3) (2016) 252-8. 
[186] OECD, Histopathology Guidance Document for the  Medaka Extended One-
Generation Reproduction Test (MEOGRT), OECD2014. 
[187] O. Midasch, H. Drexler, N. Hart, M.W. Beckmann, J. Angerer, Transplacental 
exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot 
study, Int Arch Occup Environ Health 80(7) (2007) 643-8. 
[188] C.R. Stein, M.S. Wolff, A.M. Calafat, K. Kato, S.M. Engel, Comparison of 
polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a 
pilot study, Reprod Toxicol 34(3) (2012) 312-6. 
[189] Z. Zeng, B. Song, R. Xiao, G. Zeng, J. Gong, M. Chen, P. Xu, P. Zhang, M. Shen, 
H. Yi, Assessing the human health risks of perfluorooctane sulfonate by in vivo 
and in vitro studies, Environ Int 126 (2019) 598-610. 
[190] M.S. Jensen, B. Norgaard-Pedersen, G. Toft, D.M. Hougaard, J.P. Bonde, A. 
Cohen, A.M. Thulstrup, R. Ivell, R. Anand-Ivell, C.H. Lindh, B.A. Jonsson, 
Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal 
trends and timing of amniocentesis in pregnancy, Environ Health Perspect 120(6) 
(2012) 897-903. 
[191] Q. Sun, G. Zong, D. Valvi, F. Nielsen, B. Coull, P. Grandjean, Plasma 
Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A 




[192] B.J. Apelberg, F.R. Witter, J.B. Herbstman, A.M. Calafat, R.U. Halden, L.L. 
Needham, L.R. Goldman, Cord serum concentrations of perfluorooctane sulfonate 
(PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth, 
Environ Health Perspect 115(11) (2007) 1670-6. 
[193] C. Liu, K. Yu, X. Shi, J. Wang, P.K. Lam, R.S. Wu, B. Zhou, Induction of 
oxidative stress and apoptosis by PFOS and PFOA in primary cultured 
hepatocytes of freshwater tilapia (Oreochromis niloticus), Aquat Toxicol 82(2) 
(2007) 135-43. 
[194] Y. Qian, A. Ducatman, R. Ward, S. Leonard, V. Bukowski, N. Lan Guo, X. Shi, V. 
Vallyathan, V. Castranova, Perfluorooctane sulfonate (PFOS) induces reactive 
oxygen species (ROS) production in human microvascular endothelial cells: role 
in endothelial permeability, J Toxicol Environ Health A 73(12) (2010) 819-36. 
[195] T. Chen, L. Zhang, J.Q. Yue, Z.Q. Lv, W. Xia, Y.J. Wan, Y.Y. Li, S.Q. Xu, 
Prenatal PFOS exposure induces oxidative stress and apoptosis in the lung of rat 
off-spring, Reprod Toxicol 33(4) (2012) 538-545. 
[196] B. Yang, W. Zou, Z. Hu, F. Liu, L. Zhou, S. Yang, H. Kuang, L. Wu, J. Wei, J. 
Wang, T. Zou, D. Zhang, Involvement of oxidative stress and inflammation in 
liver injury caused by perfluorooctanoic acid exposure in mice, Biomed Res Int 
2014 (2014) 409837. 
[197] M.K. Kwak, K. Itoh, M. Yamamoto, T.W. Kensler, Enhanced expression of the 
transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant 
response element-like sequences in the nrf2 promoter, Mol Cell Biol 22(9) (2002) 
2883-92. 
[198] F.L. Graham, J. Smiley, W.C. Russell, R. Nairn, Characteristics of a human cell 
line transformed by DNA from human adenovirus type 5, J Gen Virol 36(1) 
(1977) 59-74. 
[199] S.N. Dezfuli, Z.G. Huan, J.M.C. Mol, M.A. Leeflang, J. Chang, J. Zhou, Influence 
of HEPES buffer on the local pH and formation of surface layer during in vitro 
degradation tests of magnesium in DMEM, Prog Nat Sci-Mater 24(5) (2014) 531-
538. 
[200] B. Morgan, M.C. Sobotta, T.P. Dick, Measuring E(GSH) and H2O2 with roGFP2-
based redox probes, Free Radic Biol Med 51(11) (2011) 1943-51. 
[201] M. Furukawa, Y. Xiong, BTB protein Keap1 targets antioxidant transcription factor 
Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase, Mol Cell Biol 25(1) (2005) 
162-71. 
[202] G. Da Silva Xavier, The Cells of the Islets of Langerhans, J Clin Med 7(3) (2018). 
	
	 145 
[203] U. EPA, Health Effects Support Document for Perfluorooctane Sulfonate (PFOS),  
(2016). 
[204] U. EPA, Basic Information on PFAS,  (2018). 
[205] J.E. Gerich, Somatostatin and diabetes, Am J Med 70(3) (1981) 619-26. 
[206] E.P. Hines, S.S. White, J.P. Stanko, E.A. Gibbs-Flournoy, C. Lau, S.E. Fenton, 
Phenotypic dichotomy following developmental exposure to perfluorooctanoic 
acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and 
insulin, and overweight in mid-life, Mol Cell Endocrinol 304(1-2) (2009) 97-105. 
[207] L. Wang, Y. Wang, Y. Liang, J. Li, Y. Liu, J. Zhang, A. Zhang, J. Fu, G. Jiang, 
PFOS induced lipid metabolism disturbances in BALB/c mice through inhibition 
of low density lipoproteins excretion, Sci Rep 4 (2014) 4582. 
[208] A. Segerstolpe, A. Palasantza, P. Eliasson, E.M. Andersson, A.C. Andreasson, X. 
Sun, S. Picelli, A. Sabirsh, M. Clausen, M.K. Bjursell, D.M. Smith, M. Kasper, C. 
Ammala, R. Sandberg, Single-Cell Transcriptome Profiling of Human Pancreatic 
Islets in Health and Type 2 Diabetes, Cell Metab 24(4) (2016) 593-607. 
[209] A. Stein, Decreasing variability in your cell culture, Biotechniques 43(2) (2007) 
228-9. 
[210] C.E. Jochems, J.B. van der Valk, F.R. Stafleu, V. Baumans, The use of fetal bovine 
serum: ethical or scientific problem?, Altern Lab Anim 30(2) (2002) 219-27. 
[211] S.J. Lupton, J.K. Huwe, D.J. Smith, K.L. Dearfield, J.J. Johnston, Distribution and 
excretion of perfluorooctane sulfonate (PFOS) in beef cattle (Bos taurus), J Agric 
Food Chem 62(5) (2014) 1167-73. 
[212] M. Reynolds, Plasma and blood volume in the cow using the T-1824 hematocrit 
method, Am J Physiol 173(3) (1953) 421-7. 
[213] R. Vestergren, F. Orata, U. Berger, I.T. Cousins, Bioaccumulation of perfluoroalkyl 
acids in dairy cows in a naturally contaminated environment, Environmental 
science and pollution research international 20(11) (2013) 7959-69. 
[214] J. Kowalczyk, S. Ehlers, A. Oberhausen, M. Tischer, P. Furst, H. Schafft, M. 
Lahrssen-Wiederholt, Absorption, distribution, and milk secretion of the 
perfluoroalkyl acids PFBS, PFHxS, PFOS, and PFOA by dairy cows fed naturally 
contaminated feed, J Agric Food Chem 61(12) (2013) 2903-12. 
[215] M.K. Tuck, D.W. Chan, D. Chia, A.K. Godwin, W.E. Grizzle, K.E. Krueger, W. 
Rom, M. Sanda, L. Sorbara, S. Stass, W. Wang, D.E. Brenner, Standard operating 
procedures for serum and plasma collection: early detection research network 
consensus statement standard operating procedure integration working group, J 
Proteome Res 8(1) (2009) 113-7. 
	
	 146 
[216] X. Zhang, L. Chen, X.C. Fei, Y.S. Ma, H.W. Gao, Binding of PFOS to serum 
albumin and DNA: insight into the molecular toxicity of perfluorochemicals, 
BMC Mol Biol 10 (2009) 16. 
[217] P.D. Jones, W. Hu, W. De Coen, J.L. Newsted, J.P. Giesy, Binding of 
perfluorinated fatty acids to serum proteins, Environ Toxicol Chem 22(11) (2003) 
2639-49. 
[218] J. Xu, P. Shimpi, L. Armstrong, D. Salter, A.L. Slitt, PFOS induces adipogenesis 
and glucose uptake in association with activation of Nrf2 signaling pathway, 
Toxicol Appl Pharmacol 290 (2016) 21-30. 
[219] X.Z. Hu, D.C. Hu, Effects of perfluorooctanoate and perfluorooctane sulfonate 
exposure on hepatoma Hep G2 cells, Arch Toxicol 83(9) (2009) 851-61. 
[220] K.T. Eriksen, O. Raaschou-Nielsen, M. Sorensen, M. Roursgaard, S. Loft, P. 
Moller, Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, 
PFNA and PFHxA in human HepG2 cells, Mutat Res 700(1-2) (2010) 39-43. 
[221] R.S. Thomas, R.S. Paules, A. Simeonov, S.C. Fitzpatrick, K.M. Crofton, W.M. 
Casey, D.L. Mendrick, The US Federal Tox21 Program: A strategic and 
operational plan for continued leadership, ALTEX 35(2) (2018) 163-168. 
[222] M. Mastrantonio, E. Bai, R. Uccelli, V. Cordiano, A. Screpanti, P. Crosignani, 
Drinking water contamination from perfluoroalkyl substances (PFAS): an 
ecological mortality study in the Veneto Region, Italy, Eur J Public Health 28(1) 
(2018) 180-185. 
[223] J. Pi, Q. Zhang, J. Fu, C.G. Woods, Y. Hou, B.E. Corkey, S. Collins, M.E. 
Andersen, ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell 
function, Toxicol Appl Pharmacol 244(1) (2010) 77-83. 
[224] Y. Xin, G. Dominguez Gutierrez, H. Okamoto, J. Kim, A.H. Lee, C. Adler, M. Ni, 
G.D. Yancopoulos, A.J. Murphy, J. Gromada, Pseudotime Ordering of Single 
Human beta-Cells Reveals States of Insulin Production and Unfolded Protein 
Response, Diabetes 67(9) (2018) 1783-1794. 
[225] Y. Masuda, N.D. Vaziri, S. Li, A. Le, M. Hajighasemi-Ossareh, L. Robles, C.E. 
Foster, M.J. Stamos, I. Al-Abodullah, C. Ricordi, H. Ichii, The effect of Nrf2 
pathway activation on human pancreatic islet cells, PLoS One 10(6) (2015) 
e0131012. 
[226] N.C. Bramswig, L.J. Everett, J. Schug, C. Dorrell, C. Liu, Y. Luo, P.R. Streeter, A. 
Naji, M. Grompe, K.H. Kaestner, Epigenomic plasticity enables human pancreatic 
alpha to beta cell reprogramming, J Clin Invest 123(3) (2013) 1275-84. 
	
	 147 
[227] C.H. Chung, E. Hao, R. Piran, E. Keinan, F. Levine, Pancreatic beta-cell 
neogenesis by direct conversion from mature alpha-cells, Stem Cells 28(9) (2010) 
1630-8. 
[228] J. Lu, R. Jaafer, R. Bonnavion, P. Bertolino, C.X. Zhang, Transdifferentiation of 
pancreatic alpha-cells into insulin-secreting cells: From experimental models to 
underlying mechanisms, World J Diabetes 5(6) (2014) 847-53. 
[229] R. Judson, A. Richard, D.J. Dix, K. Houck, M. Martin, R. Kavlock, V. Dellarco, T. 
Henry, T. Holderman, P. Sayre, S. Tan, T. Carpenter, E. Smith, The toxicity data 
landscape for environmental chemicals, Environ Health Perspect 117(5) (2009) 
685-95. 
[230] R.C. Lewis, L.E. Johns, J.D. Meeker, Serum Biomarkers of Exposure to 
Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of 
Thyroid Function among Adults and Adolescents from NHANES 2011-2012, Int 
J Environ Res Public Health 12(6) (2015) 6098-114. 
 
